<h4>Background</h4>KRAS is among the most frequently mutated oncogenes in pancreatic, colorectal, and lung cancers, yet the structural and dynamic mechanisms by which specific coding variants alter its function remain poorly understood. This evidence concerns the gene KRAS and lung carcinoma.